retatrutide fda Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Trial of next-gen weight-loss drug

The ADA also states that these recommendations are actionable whenever these comorbidities become new clinical considerations regardless of background glucose-lowering medications

Inactivation of the cardiomyocyte glucagonlike peptide1 receptor (GLP1R) unmasks cardiomyocyteindependent GLP1Rmediated cardioprotection

I would recommend speaking to your clinician about reducing the dose of your GLP-1 and possibly prescribing a medication for nausea relief, advises Agrawal

Second, fiber from food is a natural stimulant for your body's own GLP-1 production

A conversation with your provider is always the best place to start